PortfoliosStock ScreensStocksStockXcel

Mangalam Drugs & Organics Limited

MANGALAM | NSE

29.55

INR

1.05

3.68%

MANGALAM | NSE
Loading StockChartView...

About Mangalam Drugs & Organics Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

31/03/2024

As of date

02/04/2026

Close

29.55

Open

28.00

High

29.92

Low

27.51

Mangalam Drugs & Organics Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates at VAPI in India and internationally. It offers a range of API products which include Acyclovir Amodiaquine Artemether Artesunate Atorvastatin Calcium Atazanavir Sulfate Bisoprolol Fumarate Chloroquine Phosphate and Dolutegravir Sodium; Efavirenz Emtricitabine Furosemide Hydroxychloroquine Sulphate Lumefantrine and Nimesulide; Nitrofurantoin Anhydrous and Monohydrate; Primaquine and Piperaquine Phosphate; Pregabalin Pyrimethamine Pyronaridine Tetraphosphate and Sulfadoxine; and Tenofovir Alafenamide Hemifumarate and Disoproxil Fumarate. The company also offers intermediates comprising 2-Dibutylamino-1-(27-dichloro-9H-fluorine-4-yl)-ethanol; 46-Dichloro-5-methoxy pyrimidine; 47 Dichloroquinoline; Ortho phenoxy methane sulfonanilide; and Tenofovir Alafenamide Base and Disoproxil Base. In addition it offers specialty chemicals such as Menthol; 23-Dihydrophthalazine-1 4-dione; and 4-cynoethyl-2-methyl phenol. The company was incorporated in 1972 and is based in Mumbai India.

View Less

MANGALAM | NSE

Risk
56.3
Sharpe
-1.31
Luna's Score
45/100
Recommendation
Sell

Luna says (MANGALAM | NSE)

What's Working

Low Market Beta (-0.4 to 0.8)

Value Stock (Price to Book < 3)

What's not Working

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

Loading RiskMeterView...

10 days

56.9%

1 month

56.3%

3 months

63.5%

6 months

64.3%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

1.40

Debt to equity

0.71

Debt to assets

0.29

Ent. to EBITDA

21.21

Ent. to rev.

0.81

PEG

-

Other Fundamentals

EBITDA

245.56M

MarketCap

477.89M

MarketCap(USD)

5.14M

Div. yield

-

Op. margin

5.64

Erngs. growth

14.80

Rev. growth

-12.10

Ret. on equity

-6.31

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

4.99

Range1M

8.89

Range3M

27.89

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.74

Price X volume

1.09M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Biofil Chemicals and Pharmaceuticals LimitedBIOFILCHEMDrug Manufacturers-Specialty & Generic27.43458.13M-0.44%181.382.41%
Lasa Supergenerics LimitedLASADrug Manufacturers-Specialty & Generic6.24315.52M4.87%n/a22.84%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Sagardeep Alloys LimitedSAGARDEEPCopper22.45389.73M-1.92%58.6243.14%
Heads UP Ventures LimitedHEADSUPApparel Retail6.97152.71M0.72%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA21.2124.85Par
Ent. to Revenue0.8111.40Cheaper
PE Ratio-51.36-
Price to Book1.406.83Cheaper
Dividend Yield-0.52-
Std. Deviation (3M)63.5342.17Riskier
Debt to Equity0.710.35Expensive
Debt to Assets0.290.17Expensive
Market Cap477.89M290.82BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007